Propanc Biopharma, Inc.

About Propanc Biopharma, Inc.

Propanc Biopharma, Inc. is a biotech company focused on offering new hope to cancer patients and caregivers through innovative cancer therapies. Their mission involves developing long-term therapies to suppress tumor recurrence and metastasis, targeting significant market needs in cancer treatment.

Products & Services

PRP:Lead candidate therapy that controls cancer cell migration, inhibits tumor blood vessel formation, and triggers cancer cell death.

Pancreatic Enzyme Therapy:A long-term therapy based on a pancreatic proenzyme formulation designed to suppress tumor recurrence and metastasis.

Specialties

Cancer Therapy Pancreatic Enzyme Therapy Tumor Recurrence and Metastasis Suppression Solid Tumor Treatment (Pancreatic, Ovarian, Colorectal)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 100000000 MR: - FA: up to $100 million FAN: 100000000	D: 2025-11-10 FD: 2025-11-10	1 investors
2	RT: Series C T: - FT: Series C	A: 100000000 MR: - FA: up to $100 million FAN: 100000000	D: 2025-10-15 FD: 2025-10-15	1 investors
3	RT: Series C Convertible Preferred Stock T: - FT: Series C Convertible Preferred Stock	A: 100000000 MR: - FA: up to $100 million FAN: 100000000	D: 2025-10-15 FD: 2025-10-15	1 investors
4	RT: Asset Acquisition Plan T: - FT: Asset Acquisition Plan	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2025-09-02 FD: 2025-09-02	-
5	RT: Public Offering T: - FT: Public Offering	A: 4000000 MR: - FA: 4 million FAN: 4000000	D: 2025-08-14 FD: 2025-08-14	2 investors

Private Placement Latest

2025-11-10

$100.0M

1 investor (Pro only)

Series C 2025-10-15

$100.0M

Series C Convertible Preferred Stock 2025-10-15

$100.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James Nathanielsz

CEO and Executive Chairman

D

Dr. Julian Kenyon, M.D.

Chief Scientific Officer

J

Josef Zelinger

Non-Executive Director

D

Dr. Julian Kenyon

Chief Scientific Officer

P

Professor Klaus Kutz

Chief Medical Officer

J

Jeannine Zimmerman

Chief Financial Officer

View 13 more team members with Pro

Unlock Full Team Directory

Recent News